• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

3745350 Canada Inc

YMI:US

Acquired

Company Profile for 3745350 Canada Inc (YMI)

3745350 Canada Inc. is developing cancer drugs based on technologies licensed primarily from international academic centers. The Company is currently developing a small molecule chemopotentiator for metastatic breast cancer, an EGFr humanized monoclonal antibody, and a GnRH cancer vaccine. 3745350 Canada is also supporting the preclinical development of additional cancer products.

Contact Information

3745350 Canada Inc

5045 Orbitor Drive
Building 11 Suite 400
Mississauga, ON L4W 4Y4
Canada
Phone: 1-905-629-9761
Fax: 1-905-629-4959

Key Executives for 3745350 Canada Inc (YMI)

Leonard Vernon "Len"VP:Finance & AdministrationWendy ChapmanVP:Clinical Operations
Ernest WongVP:Business DevelopmentJames SmithVP:Corp Comm/Investor Relations
Gregg SmithVP:Drug Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil